Inc. Magazine Names InVivo Therapeutics CEO Frank Reynolds one of ‘America’s Most Innovative Entrepreneurs’
CAMBRIDGE, Mass.-(Business Wire)-September 28, 2009 - Frank Reynolds, InVivo Therapeutics President and CEO, has been identified as one of ‘‘America’s most innovative entrepreneurs’ in the October 2009 issue of Inc. Magazine. In the article entitled “The New and Improved You,” Inc. highlights ten medical technologies being developed to treat different parts of the body, including a section on “The Spine” featuring Reynolds and InVivo Therapeutics.
The article, which breaks down the body into nine sections, the Eyes, the Ears, the Heart, the Spine, the Bladder, the Hips, the Arms, the Legs, and the Knees, describes the newest technologies that are working to keep quality of life up, and health care expenses down. Being recognized as one of the “biggest, most important trends in medical technology” is an honor and a thrill for Reynolds and his InVivo team.
“All scientific development is a team effort so I accept any accolades I receive on behalf of my team at InVivo Therapeutics Corporation,” says Reynolds. “We have worked diligently for the past four and a half years to bring the first treatment for spinal cord injury to market, and look forward to the day we receive FDA approval for our first technology.”
InVivo Therapeutics Corporation is a Cambridge, MA medical device company focused on combining polymers and stem cells to restore function in individuals paralyzed as a result of traumatic spinal cord injury. The company was founded in 2005 on the basis of research initiated in the laboratories of Robert Langer, PhD, of the Massachusetts Institute of Technology, Jay Vacanti, MD, of the Massachusetts General and Children’s Hospitals in Boston, and Yang Teng, PhD, MD, of Harvard's Brigham and Women's Hospital.
 |
 |
 |
|
||
 |
|
 |
|
||
Search Our News Using Google Search
Can't find what you want? Try using Google:
